Vol. 23 No. 2(part1) (2018)

CLINICAL MEDICINE

• Cognitive impairments in patients with heart failure of ischemic genesis.

  V. Ye. Azarenko, V. A. Potabashniy, V. I. Fesenko, O. V. Kniazieva

  7-9

  • PDF (Українська)

• Changes of platelets activity in patient swith COPD and concomitant arterial hypertension under the influence of L-arginine.

  О. М. Kovalenko

  9-14

  • PDF (Українська)

• Phenotypic symptoms of conjugate tissue dysplasia in persons of young age with mitral valve prolapse.

  M. A. Kuznetsova

  15-18

  • PDF (Українська)

• The level of proteinuria and the state of endothelial function in patients with chronic kidney disease combined with subclinical hypothyroidism under the influence of combined antihypertensive therapy.

  O. V. Kuryata, I. P. Garmish

  19-24

  • PDF (Українська)

• The level of Β-2-microglobulin, albuminuria in patients with chronic heart failure and atrial fibrillation depending on the functional state of the kidneys.

  Muhammad Muhammad

  25-32

  • PDF (Українська)

• Criteria of vital activity lesions as a methodological basis for determining disability.

  L. Naumenko, I. Borisova, V. Berezovskyi, H. Fesenko, T. Zub, D. Chub

  32-36

  • PDF (Українська)

• The influence of adequate drug therapy on the clinical symptoms and level of serum amyloid A in patients with chronic obstructive pulmonary disease.

  T. A. Pertseva, D. S. Koval

  36-41

  • PDF (Українська)

• Possible predictors of depressive syndrome in patients with chronic obstructive pulmonary disease.

  T. O. Pertseva, L. I. Konopkina, Yu. V. Guba

  41-45

  • PDF (Українська)

• Daily profile and variability of blood pressure in patients with arterial hypertension (AH) in combination with COPD.

  V. A. Potabashniy, V. I. Fesenko, T. Z. Burtniak

  46-50

  • PDF (Українська)

• The use of trypsin-like blood activity as a marker of pulmonary fibrosis severity.

  V. V. Rodionova, O. V. Karaseva

  50-56

  • PDF (Українська)

• Role of biomarkers in diagnostics, stratification of risk and prognosis of heart failure.

  О. О. Khanyukov, L. V. Sapozhnychenko

  56-63

  • PDF (Українська)

• Features of the myocardial infarction course in patients with a permanent atrial fibrillation.

  M. I. Yalovenko, O. O. Khaniukov

  64-68

  • PDF (Українська)

• Galectin-3, advanced glycated end-products serum levels, endothelial function and cardiac hemo¬dynamics in post infarction heart failure patients with reduced and preserved ejection fraction.

  O. Kuryata, A. Zabida, O. Sirenko

  69-74

  • PDF

• Endothelial function, systemic inflammation and cardiac hemodynamics in different age patients with post infarction chronic heart failure.

  Zabida Abdunaser A.M.